Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 538
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Front Endocrinol (Lausanne) ; 14: 1148556, 2023.
Article in English | MEDLINE | ID: mdl-37593349

ABSTRACT

Objective: To evaluate the effect of vitamin D supplementation on pregnancy and ovulation in patients with polycystic ovary syndrome. Method: We searched Pubmed, Medline (via Ovid, 1974 to 2020), EMBASE (via Ovid, 1974 to 2020), Cochrane Central Register of Controlled Trials (via Ovid), Web of Science, CNKI, WangFang and the Vip database from inception until April 2021. Two researchers independently screened articles, collected data and evaluated the quality, with Review manager 5.3 for meta-analysis. Results: Totally 20 randomized controlled studies with 1961 subjects were included. Meta analysis showed that pregnancy rate [RR=1.44 (1.28, 1.62), p<0.00,001], ovulation rate [RR=1.42 (1.14, 1.78), p=0.002] and matured oocytes rate [RR=1.08 (1.03, 1.13), p=0.002] of vitamin D supplementation group were significantly higher than those of control group. Meanwhile, early miscarriage rate [RR=0.44 (0.30, 0.66), p<0.00,001], androgen level [MD=-2.31 (-3.51, -1.11), p=0.0002], luteinizing hormone [MD=-1.47 (-2.57, -0.36), p=0.009], follicle stimulating hormone [MD=-0.15 (-0.24, -0.05), p=0.002], and premature delivery rate [RR=0.38, 95% CI (0.21, 0.70), p=0.002] were declined significantly than the controls. However, only one article suggested that the progesterone [MD=6.52 (4.52, 8.52), p<0.05] in the vitamin D intervention group was increased. There was no notable difference in the biochemical pregnancy rate [RR=0.95 (0.55, 1.63), p=0.84], gestational hypertension rate [RR=0.40, 95% CI (0.15, 1.11), p=0.08], gestational diabetes mellitus rate [RR=0.27, 95% CI (0.05, 1.39), p=0.11], fertilization rate [RR=1.05 (1.00, 1.10), p=0.04], cleavage rate [RR=1.03 (0.99, 1.06), p=0.17], high-quality embryo rate [RR=1.08 (0.98, 1.20), p=0.10], endometrial thickness [MD=0.10], 77 (-0.23, 1.77), p=0.13], estrogen level [MD=-0.34 (-1.55, 0.87), p=0.59], LH/FSH [MD=-0.14, 95% CI (-0.48, 0.20), p=1.00] and anti-Mullerian hormone [MD=-0.22 (-0.65, 0.21), p=0.32]. Conclusion: Vitamin D supplementation contribute to the higher pregnancy and ovulation rates, and lower androgen, LH, FSH and early miscarriage rates in women with PCOS, regardless of the use of ovulation induction drugs or assisted reproductive technologies. However, no significant improvement was observed in fertilization rate or cleavage rate. Due to the limitation in quality of involved studies, more high-quality RCTs are needed for further validation. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42021250284.


Subject(s)
Abortion, Spontaneous , Ovulation , Polycystic Ovary Syndrome , Vitamin D , Female , Humans , Pregnancy , Androgens , Dietary Supplements , Follicle Stimulating Hormone, Human , Ovulation/drug effects , Polycystic Ovary Syndrome/complications , Vitamin D/administration & dosage , Vitamin D/adverse effects
2.
J Ovarian Res ; 15(1): 4, 2022 Jan 06.
Article in English | MEDLINE | ID: mdl-34991678

ABSTRACT

Polycystic ovary syndrome (PCOS) is an inflammatory endocrine-metabolic disorder related to reproductive system characterized by polycystic ovarian morphology, androgen excess, and chronic anovulation. Current treatments haven't been very successful in PCOS treatment and the problem still remains as a challenge. Therefore, new approaches should be applied to overcome the disease. Previous studies demonstrated immunomodulatory effects of R10 fraction of garlic in the treatment of inflammatory conditions such as cancer. Considering previous studies suggesting immunomodulatory therapy for PCOS, therapeutic effects of R10 fraction was evaluated in a mouse model of PCOS. To do so, PCOS was developed by intramuscular injection of estradiol valerate. Treatment with R10 fraction, isolated from garlic, was performed and the alterations in hormonal levels (estradiol, progesterone, and testosterone), T cell polarization markers (IFN-γ, IL-4, and IL-17), and expression of fertility-related genes (Gpx3 and Ptx3) were evaluated. The results showed that hormonal levels were elevated in PCOS model comparing to normal animals but were markedly modulated after treatment with R10 fraction. Moreover, a severe disturbance in T cell polarization with a significant reduction of fertility-related genes expression were detected in PCOS-induced ovaries. Treatment with R10 fraction also represented modulatory effects on T cell polarization by increasing IL-4 and decreasing IL-17 and IFN-γ levels. Accordingly, fertility-related genes were also modulated following treatment with R10 fraction in PCOS. Our study elucidated that R10 fraction of garlic possess immunomodulatory effects alleviating PCOS symptoms. This approach could be adjusted to give rise the optimum therapeutic results and considered as a candidate therapeutic approach for PCOS.


Subject(s)
Garlic/chemistry , Immunomodulating Agents/therapeutic use , Plant Extracts/therapeutic use , Polycystic Ovary Syndrome/drug therapy , Animals , Cytokines/metabolism , Disease Models, Animal , Estradiol/toxicity , Female , Fertilization/drug effects , Fertilization/genetics , Gonadal Steroid Hormones/blood , Immunomodulating Agents/chemistry , Mice , Ovary/drug effects , Ovary/metabolism , Ovulation/drug effects , Ovulation/genetics , Plant Extracts/chemistry , Polycystic Ovary Syndrome/chemically induced , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism
3.
Sci Rep ; 11(1): 23171, 2021 11 30.
Article in English | MEDLINE | ID: mdl-34848807

ABSTRACT

Dairy farming in tropical climates is challenging as heat stress can impair reproduction in cows. Previous studies have demonstrated the beneficial effects of beta-carotene supplementation on bovine reproductive performance. This study was performed in Thailand, where the temperature-humidity index (THI) during the experimental periods was measured to range from 78.4 to 86.1. Lactating Holstein cows classified as repeat breeders (previous artificial insemination [AI] failures) were randomly assigned into two treatments, control treatment (T1; received placebo, n = 200) and test treatment (T2; received 400 mg/h/day of beta-carotene, n = 200). All cows were subjected to a protocol for synchronization of ovulation and timed artificial insemination (TAI). The day of the 1st ovulation synchronized protocol was defined as day 0, and the total experimental period was 160 days. Daily placebo or beta-carotene supplements were given orally on day 0 and each subsequent day of the experiment. Diagnosis of pregnancy was performed using ultrasound on day 30 after insemination. Non-pregnant cows were subjected to further ovulation synchronizations (maximum of four) and TAI over a period of 160 days. Milk samples were collected every ten days throughout the experiment. The samples were analyzed for beta-carotene concentration, superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities. The pregnancies per AI of the cows in T2 were significantly greater than that of T1 from the 2nd to 4th TAI. During the entire experimental period, the pregnancies in T2 were significantly greater than that of T1. Cox's proportional hazards regression model data indicated a 44% greater probability of pregnancy for cows receiving beta-carotene. The concentrations of milk beta-carotene in T2 were significantly greater than T1 from the 2nd to 4th TAI. Significantly greater SOD and GPx activities were observed in T2 than T1, suggesting a reduction of oxidative stress in cows treated with beta-carotene. Dietary supplementation with beta-carotene thus improves the reproductive performance of repeat breeders exposed to heat stress, possibly by reducing oxidative stress.


Subject(s)
Animal Feed , Dietary Supplements , Insemination, Artificial/veterinary , Reproduction/drug effects , beta Carotene/therapeutic use , Animals , Biotechnology/methods , Cattle , Dinoprost/pharmacology , Estrus Synchronization , Female , Gonadotropin-Releasing Hormone/administration & dosage , Humidity , Lactation/drug effects , Least-Squares Analysis , Ovulation/drug effects , Pregnancy , Pregnancy, Animal , Progesterone/pharmacology , Proportional Hazards Models , Regression Analysis , Temperature , Thailand
4.
Phytomedicine ; 91: 153654, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34333328

ABSTRACT

BACKGROUND: Polycystic ovary syndrome (PCOS) is a clinical syndrome with reproductive and endocrine disorders. Berberine is a monomer from Chinese herbs such as Coptis chinensis, whose effect on improving ovulation and endometrial receptivity of PCOS is uncertain. PURPOSE: To evaluate the effect of berberine on improving PCOS and explore the mechanism. METHODS: The rat model of PCOS was induced by intraperitoneal injection of testosterone propionate. Then they was divided into model (Mod) group, low-dose of berberine (BL) group, high-dose of berberine (BH) group and metformin (Met) group as well as a control (Con) group was established. Ovary morphology, hormone level, glucolipid metabolism were measured. UID-mRNA-seq of ovary tissue was conducted to seek the mechanism of berberine on improving ovulation. Three biomarkers of endometrial receptivity were also examined in endometrium by immunohistochemistry. RESULTS: The number of cystic follicles was increased while the number of corpus luteum was decreased in the rats of Mod group. These changes could be reversed by high-dose of berberine intervention. Berberine could also decrease the levels of serum luteinizing hormone (LH) and total cholesterol (TC) in PCOS rats. Meanwhile, berberine improved the impairment of abnormal oral glucose tolerance without affecting fasting insulin level and Homeostasis model assessment-insulin resistance (HOMA-IR). Luteinizing hormone/ choriogonadotropin receptor (LHCGR) and cytochrome P450 Family 19 Subfamily A Member 1 (CYP19A1) were focused via RNA-seq of ovary. Protein expression in ovary and mRNA expression in granulosa cell of LHCGR and CYP19A1 were decreased in Mod group and rescued by the intervention of berberine. A decrease of endometrial thickness and an increase of integrin αvß3 and lysophosphatidic acid receptor 3 (LPAR3) protein expression were observed in Mod group, which could be also reversed by berberbine. CONCLUSIONS: Berberine could improve ovulation in PCOS and the mechanism might be associated with up-regulating LHCGR and CYP19A1. Berberine could also improve endometrial receptivity through down-regualting αvß3 and LPAR3.


Subject(s)
Berberine , Ovulation/drug effects , Polycystic Ovary Syndrome , Animals , Berberine/pharmacology , Endometrium/drug effects , Female , Metformin , Polycystic Ovary Syndrome/drug therapy , Rats
5.
Anim Sci J ; 92(1): e13550, 2021.
Article in English | MEDLINE | ID: mdl-33899985

ABSTRACT

This research aimed to determine whether the astragalus polysaccharide (AP) can improve the production performance and gut microbiota in Chongren hens.120 Chongren hens (240-d old) were randomly allocated into 4 treatments with 30 hens and fed with a control basal diet (CON) or CON supplemented with the different levels of AP (100, 200, and 400 mg/kg) for 56 d. The egg production and feed conversion ratio were decreased (p < .05) with the levels of AP. The yolk weight, yolk color, eggshell thickness, eggshell redness index and egg shell yellowness were increased (p < .05). AP supplementation increased CAT and T-AOC and SOD, and decreased MDA (p < .05). Supplementation of AP decreased IL-2, IL-6 and TNF-α levels (p < .05), but increased the IL-4 level in the liver (p < .05). The villus heights of duodenum, jejunum ileum, the crypt depth and V/C in the jejunum were increased (p < .05). Dietary supplementation of 200 mg/kg AP increased (P relative abundances of Firmicutes and Lactobacteriaceae in the cecum of Chongren hens. In conclusion, addition of AP improved the production performance, egg quality, antioxidant function, and intestinal morphology in hens, which might be associated with the gut microbiota.


Subject(s)
Astragalus Plant/chemistry , Chickens/microbiology , Chickens/physiology , Diet/veterinary , Dietary Supplements , Eggs , Food Quality , Gastrointestinal Microbiome/drug effects , Ovulation/drug effects , Polysaccharides/administration & dosage , Polysaccharides/pharmacology , Animals , Antioxidants , Chickens/blood , Female , Inflammation Mediators/blood , Interleukin-2/blood , Interleukin-4/metabolism , Interleukin-6/blood , Jejunum/drug effects , Liver/metabolism , Polysaccharides/isolation & purification , Tumor Necrosis Factor-alpha/blood
6.
J Ethnopharmacol ; 272: 113931, 2021 May 23.
Article in English | MEDLINE | ID: mdl-33607202

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: A combination of Trachyspermum ammi L., Curcuma longa L., Cuminum cyminum L., Trigonella foenum-graecum L., Foeniculum vulgare Mill., Anethum graveolens L and Zingiber officinale Roscoe is used as immunity booster and reproductive efficiency enhancing agents in folklore medicine. AIM OF THE STUDY: The present study aimed to assess the immunomodulatory, uterine cleansing and reproduction enhancing effects of polyherbal mixture in post-partum buffaloes. MATERIALS AND METHODS: Enzyme linked immunosorbent assay (ELISA) was used to investigate the effects of polyherbal mixture feeding on for quantification of neutrophil functions and blood progesterone hormone estimation. Ultrasonography was used to assess the status of uterine involution, fluid in uterus and ovarian follicular status. Quantitative real time PCR (qRT-PCR) was used to measure the expression of chemokine genes CXCR1, CXCR2 AND IL-8. Artificial insemination with cryopreserved semen was used to breed the animals. Reproductive efficiency parameters were assessed using standard calculation methods. RESULTS: Neutrophil functions and transcriptional abundance of chemokine genes were significantly (P < 0.05) higher in buffaloes supplemented with polyherbal mixture compared to buffaloes in control group. The rate of cervical and uterine involution was significantly (P < 0.05) higher in treatment group compared to control group. The service period was shorter, days to first insemination was earlier and the number of services per conception was lower in buffaloes supplemented with polyherbal mixture compared to the buffaloes in control group. The proportion of buffaloes with large ovarian follicles within 28 days of post-partum was also significantly (P < 0.05) higher in treatment group compared to the control group. CONCLUSIONS: The polyherbal mixture used in the study improved the immunity of the buffaloes, facilitated early involution of cervix and uterus, efficient cleansing of lochia and improved subsequent fertility. It has the potential to be used in dairy animals for improving post-partum reproductive efficiency.


Subject(s)
Buffaloes/immunology , Buffaloes/metabolism , Menstrual Cycle/drug effects , Plants, Medicinal , Postpartum Period , Uterus/drug effects , Animals , Cervix Uteri/drug effects , Dietary Supplements , Female , Immunity, Innate/genetics , Neutrophils/metabolism , Ovulation/drug effects , Peroxidase/blood , Postpartum Period/drug effects , Postpartum Period/physiology , Progesterone/blood , Reproduction/drug effects , Uterus/diagnostic imaging
7.
Arch Razi Inst ; 75(4): 484-490, 2021 01.
Article in English | MEDLINE | ID: mdl-33403843

ABSTRACT

The specific changes in antral follicle numbers and wave-like development have remained unrevealed in cyclic ewes fed high-protein, high-energy lupin grain for 6 days during the luteal phase of the estrous cycle (i.e., short-term nutritional flushing). This study was mainly conducted to determine ovarian effects of the 6-day lupin grain feeding in non-prolific Polish Mountain ewes, using transrectal ovarian ultrasonography and abdominal videoendoscopy. Estrus and ovulations were synchronized in 24 ewes with progestin-releasing intravaginal sponges for 12 days during the middle portion of the breeding season (September-October; 50.0458&deg;N, 19.8406&deg;E). Twenty-four ewes were assigned to three equal groups (n=8 each), including the Control group being fed the maintenance diet (i.e., hay-only), Treatment 1 receiving 500 g of lupin grain once a day, and Treatment 2 receiving 250 g of lupin grain twice a day, from days 9-14 of the synchronized estrous cycle (day 0=first ovulation of the interovulatory period studied). No differences were observed in the mean ovulation rate among the three groups of Polish Mountain ewes (P&gt;0.05). Ovarian antral follicles emerging in the penultimate wave of the estrous cycle in Treatment 2 ewes had a longer growth phase (p &lt;0.05) and attained a greater diameter (p &lt;0.05) before ovulation, in comparison to those in the other two groups. A final wave of the interovulatory interval emerged ~1 day earlier in Treatment 2 than in Treatment 1 ewes (p &lt;0.05). Nutritional supplementation with lupin grain increased the number of 3-mm follicles in Treatment 2 ewes (p &lt;0.05). The results of this study indicated that short-term nutritional flushing with lupin grain from mid- to late luteal phase did not consistently enhance ovulatory responses in non-prolific genotypes of ewes. Although the administration of lupins altered the timing of wave emergence, ovulatory follicle diameter, or duration of different stages of the follicular lifespan, it failed to increase the number of ovulatory follicles emerging in the penultimate and final waves of the estrous cycle in non-prolific Polish Mountain sheep.


Subject(s)
Dietary Supplements/analysis , Lupinus/chemistry , Ovary/physiology , Ovulation , Sheep, Domestic/physiology , Animal Feed/analysis , Animals , Corpus Luteum/drug effects , Corpus Luteum/growth & development , Diet/veterinary , Dose-Response Relationship, Drug , Female , Hysteroscopy/veterinary , Luteal Phase , Ovarian Follicle/drug effects , Ovarian Follicle/growth & development , Ovary/diagnostic imaging , Ovary/drug effects , Ovulation/drug effects , Poland , Seasons , Seeds/chemistry , Ultrasonography/veterinary
8.
Front Endocrinol (Lausanne) ; 12: 789909, 2021.
Article in English | MEDLINE | ID: mdl-35027910

ABSTRACT

Background: The efficacy of Kuntai capsule combined with letrozole (LE) in improving ovarian function of polycystic ovary syndrome (PCOS) has been evaluated before, but there is still a lack of evidence-based support for the regulation of sex hormone levels. In recent years, new randomized clinical trials (RCTs) have been reported on the effect of combined therapy on regulating sex hormone levels. Objective: We aimed to systematically evaluate the efficacy of Kuntai capsule combined with LE in the treatment of PCOS. Methods: A search across the China Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang database, PubMed, Web of Science, The Cochrane Library, and Embase was conducted on Kuntai capsule combined with LE in the treatment of PCOS. The time of the self-built database was up to April 30, 2021. RCTs of LE in the control group and LE combined with Kuntai capsule in the experimental group were selected. RevMan5.3 software was used for data analysis. Results: A total of 17 studies were gathered, which included 1,684 patients. The meta-analysis results showed that the total effective rate of the combined group was 93.36% and that of the LE group was 78.15%. The improvement in the ovulation rate, pregnancy rate, number of mature follicles, endometrial thickness, cervical mucus score, and serum follicle stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL) in the combined group was consistent with the results of a previous meta-analysis and was better than that in the LE group (p < 0.05). In addition, the combination group was better than the LE group in regulating the levels of estradiol (E2) and testosterone (T) (p < 0.05). There were no adverse drug reactions in the two groups during treatment. Conclusion: As a type of pure traditional Chinese medicine preparation, Kuntai capsule combined with LE had a better effect than LE alone in the treatment of PCOS, with advantages mainly reflected in enhancing ovarian function and regulating the levels of sex hormones in vivo, among others, but the value of combined therapy still needs to be verified by more high-quality RCTs.


Subject(s)
Aromatase Inhibitors/administration & dosage , Drugs, Chinese Herbal/administration & dosage , Gonadal Hormones , Letrozole/administration & dosage , Ovary/drug effects , Polycystic Ovary Syndrome/drug therapy , Drug Therapy, Combination , Female , Gonadal Hormones/blood , Humans , Ovarian Function Tests/methods , Ovary/physiology , Ovulation/drug effects , Ovulation/physiology , Polycystic Ovary Syndrome/blood , Randomized Controlled Trials as Topic/methods
9.
Nat Rev Endocrinol ; 17(2): 83-96, 2021 02.
Article in English | MEDLINE | ID: mdl-33288917

ABSTRACT

The onset of puberty and the female ovulatory cycle are important developmental milestones of the reproductive system. These processes are controlled by a tightly organized network of neurotransmitters and neuropeptides, as well as genetic, epigenetic and hormonal factors, which ultimately drive the pulsatile secretion of gonadotropin-releasing hormone. They also strongly depend on organizational processes that take place during fetal and early postnatal life. Therefore, exposure to environmental pollutants such as endocrine-disrupting chemicals (EDCs) during critical periods of development can result in altered brain development, delayed or advanced puberty and long-term reproductive consequences, such as impaired fertility. The gonads and peripheral organs are targets of EDCs, and research from the past few years suggests that the organization of the neuroendocrine control of reproduction is also sensitive to environmental cues and disruption. Among other mechanisms, EDCs interfere with the action of steroidal and non-steroidal receptors, and alter enzymatic, metabolic and epigenetic pathways during development. In this Review, we discuss the cellular and molecular consequences of perinatal exposure (mostly in rodents) to representative EDCs with a focus on the neuroendocrine control of reproduction, pubertal timing and the female ovulatory cycle.


Subject(s)
Endocrine Disruptors/pharmacology , Environmental Exposure , Epigenesis, Genetic/drug effects , Estradiol/metabolism , Gonadotropin-Releasing Hormone/drug effects , Hypothalamus/drug effects , Neurons/drug effects , Animals , Cell Movement , DNA Methylation/drug effects , Feedback, Physiological/drug effects , Female , GABA Agents/metabolism , Germ Cells/metabolism , Glutamic Acid/metabolism , Gonadotropin-Releasing Hormone/metabolism , Histone Code/drug effects , Humans , Hypothalamus/cytology , Hypothalamus/growth & development , Hypothalamus/metabolism , Kisspeptins/metabolism , Male , Neurons/metabolism , Ovulation/drug effects , Ovulation/metabolism , Pregnancy , Prenatal Exposure Delayed Effects
10.
Anim Reprod Sci ; 223: 106631, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33137692

ABSTRACT

Objectives were to evaluate effects of a smaller than typically used dose of equine chorionic gonadotropin (eCG) during a fixed-time artificial insemination (FTAI) treatment regimen. Transrectal ultrasonic (US) examinations were conducted on dairy cows on Day 0 (D0) and the treatment regimen was initiated with administrations of an intravaginal progesterone (P4) implant, estradiol benzoate (im), and prostaglandin F2α (PGF2α; im). On D8, the P4 implant was removed and PGF2α and estradiol cypionate were administered to all animals. Subsequently, cows were randomly assigned to three groups and eCG was administered to Groups 1, 2, and 3 in doses of 300 (im); 100 (im); and 100 (Baihui acupoint) IUs, respectively. The B-mode and power-flow US cineloops were performed to assess follicular dynamics and evaluate various morphological and vascular characteristics of the corpus luteum. Blood samples were collected to quantify serum P4 concentrations. There were no differences between the ovulation synchronization treatment regimens for all follicular dynamic variables tested; however, cows in Group 3 differed from Group 2 having a larger follicle diameter (FD) on D10 (P = 0.06) and larger preovulatory FD (P = 0.09), as well as a blood perfusion area of the dominant follicle wall on D8 (P = 0.07). There were no differences in responses to the ovulation synchronization treatment regimens for the luteal variables evaluated subsequent to ovulation. In conclusion, the Baihui acupoint was effective as an alternative route for eCG dose reduction when FTAI treatment regimens were imposed without detrimentally affecting values for reproductive variables.


Subject(s)
Acupuncture Points , Cattle , Chorionic Gonadotropin/pharmacology , Corpus Luteum/drug effects , Ovarian Follicle/drug effects , Ovulation/drug effects , Animals , Chorionic Gonadotropin/administration & dosage , Corpus Luteum/physiology , Dinoprost/administration & dosage , Dinoprost/pharmacology , Dose-Response Relationship, Drug , Estradiol/administration & dosage , Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrus Synchronization , Female , Insemination, Artificial/veterinary , Progesterone/administration & dosage , Progesterone/pharmacology
11.
Poult Sci ; 99(11): 6233-6238, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33142541

ABSTRACT

Zinc is vital for proper functioning of an animal. Two sources of zinc are commonly supplemented in animal feed, organic and inorganic zinc, and there are reports that the former is absorbed to a greater extent than the latter. We hypothesized that supplementary zinc would increase zinc content in eggs of laying hens and that organic zinc would be more effective than inorganic zinc. To test these hypotheses, we examined the effect of levels and sources of supplemental dietary zinc on average daily feed intake (ADFI), egg production, and zinc content in eggs and on serum antioxidant capacity and zinc concentration in laying hens. A total of 720 Roman laying hens (21-week-old) were randomly assigned to 5 treatment groups with 6 replicates, with 24 hens in each replicate. Two sources of zinc, organic (zinc amino acid complex) and inorganic (zinc sulfate), each with 2 levels, low (35 mg/kg) and high (70 mg/kg), comprised 4 treatment groups, and a control group without supplementary zinc was the fifth group. Seven days were allowed for adjustment to the conditions, and then measurements were taken over 42 D. There was no difference in ADFI, average egg weight (EW), ADFI-to-EW ratio, and egg quality (P > 0.05) among the 5 treatment groups; supplemental zinc increased serum concentrations of Zn2+ and Cu-Zn superoxide dismutase and tended to increase superoxide dismutase content (P = 0.065). Zinc content in eggs increased linearly with supplementary organic zinc (N = 18, R2 = 0.363, P = 0.008) and with supplementary inorganic zinc (N = 18, R2 = 0.366, P = 0.008) treatment, but there was no difference between the source treatments of zinc. Therefore, our first hypothesis was supported, but our second one was not supported. We concluded that zinc supplementation is effective in enhancing zinc content in eggs and in improving antioxidant capacity in laying hens.


Subject(s)
Antioxidants , Chickens , Dietary Supplements , Ovulation , Ovum , Zinc , Animal Feed/analysis , Animals , Antioxidants/metabolism , Chickens/blood , Chickens/physiology , Diet/veterinary , Eggs/analysis , Eggs/standards , Female , Ovulation/drug effects , Ovum/chemistry , Random Allocation , Zinc/analysis , Zinc/blood , Zinc/pharmacology
12.
J Physiol Pharmacol ; 71(2)2020 Apr.
Article in English | MEDLINE | ID: mdl-32776907

ABSTRACT

This study aims to observe the efficacy of supplemented Er-xian decoction combined with acupoint application in treating poor ovarian response (POR). This study was a randomized controlled trial. A total of 80 patients, who were treated in the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine from January 2016 to December 2017, were divided into two groups by tables of random numbers: experimental group (n = 40), and control group (n = 40). In the experimental group, patients orally received supplemented Er-xian decoction with acupoint application. In the control group, a Kuntai capsule was administered according to the course of treatment. The therapeutic effects in the two groups were observed and compared. In the experimental group, the total effective rate was 90%, the cure rate was 15% (six patients), the markedly effective rate was 35% (14 patients), the effective rate was 40% (16 patients), and the ineffective rate was 10% (four patients). In the control group, the total effective rate was 50%, the cure rate was 5% (two patients), the markedly effective rate was 15% (six patients), the effective rate was 30% (12 patients), and the ineffective rate was 50% (20 patients). The differences were statistically significant (P > 0.05). Definite efficacy was observed when a poor ovarian response was treated by supplemented Er-xian decoction combined with acupoint application. Improvements in perimenopausal symptoms, menstruation conditions, hormone levels, inhibin B (INHB), and antral follicle count (AFC) were markedly better in the experimental group than in the control group. In addition, the treatment was safe and had few side effects.


Subject(s)
Acupuncture Points , Drugs, Chinese Herbal/therapeutic use , Fertilization in Vitro/methods , Ovarian Neoplasms/therapy , Ovulation/drug effects , Adult , Female , Follicle Stimulating Hormone/metabolism , Humans , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Reproductive Health , Treatment Outcome
13.
Development ; 147(20)2020 10 16.
Article in English | MEDLINE | ID: mdl-32820022

ABSTRACT

Seipin, an evolutionary conserved protein, plays pivotal roles during lipid droplet (LD) biogenesis and is associated with various human diseases with unclear mechanisms. Here, we analyzed Caenorhabditis elegans mutants deleted of the sole SEIPIN gene, seip-1 Homozygous seip-1 mutants displayed penetrant embryonic lethality, which is caused by the disruption of the lipid-rich permeability barrier, the innermost layer of the C. elegans embryonic eggshell. In C. elegans oocytes and embryos, SEIP-1 is associated with LDs and is crucial for controlling LD size and lipid homeostasis. The seip-1 deletion mutants reduced the ratio of polyunsaturated fatty acids (PUFAs) in their embryonic fatty acid pool. Interestingly, dietary supplementation of selected n-6 PUFAs rescued the embryonic lethality and defective permeability barrier. Accordingly, we propose that SEIP-1 may maternally regulate LD biogenesis and lipid homeostasis to orchestrate the formation of the permeability barrier for eggshell synthesis during embryogenesis. A lipodystrophy allele of seip-1 resulted in embryonic lethality as well and could be rescued by PUFA supplementation. These experiments support a great potential for using C. elegans to model SEIPIN-associated human diseases.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/embryology , Caenorhabditis elegans/genetics , Egg Shell/embryology , Genes, Helminth , Membrane Proteins/genetics , Animals , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/ultrastructure , Caenorhabditis elegans Proteins/metabolism , Dietary Supplements , Disease Models, Animal , Egg Shell/drug effects , Egg Shell/ultrastructure , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Embryo, Nonmammalian/ultrastructure , Fatty Acids, Unsaturated/pharmacology , Fertilization , Gene Deletion , Gene Expression Regulation, Developmental/drug effects , Humans , Lipid Droplets/metabolism , Lipid Droplets/ultrastructure , Lipidomics , Membrane Proteins/metabolism , Mutation/genetics , Oocytes/drug effects , Oocytes/metabolism , Oocytes/ultrastructure , Ovulation/drug effects , Permeability , Saccharomyces cerevisiae/genetics
14.
Am J Physiol Endocrinol Metab ; 319(4): E744-E752, 2020 10 01.
Article in English | MEDLINE | ID: mdl-32830548

ABSTRACT

Oxidative stress (OS) and inflammation are often present in polycystic ovary syndrome (PCOS). We examined the effects of salsalate treatment on nutrient-induced OS and inflammation, ovarian androgen secretion, ovulation, and insulin sensitivity in PCOS. Eight lean insulin-sensitive women with PCOS and eight age- and body composition-matched ovulatory controls for baseline comparison participated in the study. The women with PCOS underwent a 12-wk treatment of salsalate, a nonsteroidal anti-inflammatory drug, at a dose of 3 g daily. Markers of OS and inflammation were quantified in mononuclear cells (MNC) and plasma from blood drawn fasting and 2 h after saturated fat ingestion before and after treatment. Ovarian androgen secretion was assessed from blood drawn fasting and 24, 48, and 72 h after human chorionic gonadotropin (HCG) administration before and after treatment. Ovulation was documented based on biphasic basal body temperatures and luteal range progesterone elevations. A two-step pancreatic clamp was performed pre- and posttreatment to measure basal endogenous glucose production (EGP) and the steady-state glucose disposal rate (GDR) during the euglycemic phase and markers of OS and inflammation in MNC and plasma during the hyperglycemic phase. Salsalate administration suppressed lipid- and glucose-stimulated reactive oxygen species generation, activated nuclear factor-κB and circulating tumor necrosis factor-α, normalized basal androgen levels, and lowered HCG-stimulated androgen secretion without altering EGP or GDR. Four salsalate-treated subjects responded with two consecutive ovulations. We conclude that in PCOS, salsalate-induced suppression of OS and inflammation ameliorates ovarian androgen hypersecretion and may induce ovulation while maintaining insulin action.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Nutrients , Ovary/drug effects , Polycystic Ovary Syndrome/drug therapy , Polycystic Ovary Syndrome/physiopathology , Salicylates/therapeutic use , Adult , Androgens/metabolism , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Body Composition , Chorionic Gonadotropin/pharmacology , Female , Glucose Clamp Technique , Glucose Tolerance Test , Humans , Monocytes/metabolism , Ovulation/drug effects , Oxidative Stress , Salicylates/adverse effects
15.
Fertil Steril ; 114(2): 191-199, 2020 08.
Article in English | MEDLINE | ID: mdl-32741458

ABSTRACT

The current ovarian cycle paradigm postulates that ovulation is triggered by a critically sustained elevation of estradiol. However, an in-depth look into the published data reveals considerable uncertainty about the relative roles of progesterone and estradiol in the ovulation process.This review provides compelling evidences that the role of estradiol in ovulation has been misinterpreted and that the true physiological trigger of ovulation is a luteinizing hormone-independent preovulatory progesterone surge in the circulation to approximately 0.5 ng/mL. Furthermore, the current work reconciles the ability of progesterone to trigger ovulation, with its well-established ability to block ovulation during pregnancy, or when administered in the form of a synthetic progestin in birth control formulations and with experimental data that estradiol benzoate triggers ovulation in the complete absence of progesterone.


Subject(s)
Gonadotropins/blood , Hypothalamus/metabolism , Luteinizing Hormone/blood , Menstrual Cycle/blood , Ovary/metabolism , Ovulation/blood , Progesterone/blood , Contraceptive Agents, Hormonal/pharmacology , Estradiol/analogs & derivatives , Estradiol/blood , Estradiol/metabolism , Estradiol/pharmacology , Female , Humans , Menstrual Cycle/drug effects , Ovary/drug effects , Ovulation/drug effects , Progesterone Congeners/pharmacology , Signal Transduction
16.
J Reprod Dev ; 66(5): 475-483, 2020 Oct 13.
Article in English | MEDLINE | ID: mdl-32713881

ABSTRACT

Iron is important for many cellular functions, including ATP synthesis and cell proliferation. Insufficient of iron in the diet causes iron deficiency anemia (IDA), which often occurs in people living in the world. Since 50% of women with IDA show amenorrhea, the relationship of between iron deficiency and reproductive function was assessed using mice fed a low Fe diet (LFD). The estrous cycle in the LFD mice was blocked at diestrus, which impair follicle development, and fertility. Further, even LFD mice were injected with exogenous pregnant mare serum gonadotropin (PMSG), follicular development was ceased at the secondary follicle stage, and preovulatory follicles were not observed. Amount of ATP decreased in the ovary of the LFD mice, and expression of follicle development markers (Fshr, Cyp19a1, Ccnd2) and estradiol-17ß (E2) was low level compared to levels mice fed a normal diet. Feeding a normal diet with sufficient iron to the LFD mice for an additional 3 weeks completely reversed absence the effects of iron insufficient on the estrous cycle and infertility. Thus, iron restriction depresses ovary functions, especially follicular development from secondary follicle to antral follicles and infertility. These effects are fully reversible by supplementation of a normal diet containing iron.


Subject(s)
Iron/chemistry , Ovarian Follicle/metabolism , Adenosine Triphosphate/metabolism , Anemia, Iron-Deficiency , Animals , Aromatase/metabolism , Body Weight , Cyclin D2/metabolism , Estradiol/blood , Estrogens/metabolism , Estrous Cycle/drug effects , Female , Follicle Stimulating Hormone/metabolism , Gonadotropins, Equine/pharmacology , Iron/metabolism , Liver/metabolism , Mice , Mice, Inbred C57BL , Ovarian Follicle/drug effects , Ovary/drug effects , Ovary/metabolism , Ovulation/drug effects , Progesterone/blood , RNA, Messenger/metabolism , Receptors, FSH/metabolism
17.
BMC Vet Res ; 16(1): 207, 2020 Jun 22.
Article in English | MEDLINE | ID: mdl-32571314

ABSTRACT

BACKGROUND: The objective of this study was to investigate the metabolic and osmotic effects of different doses of glycerol or a glycerol - propylene glycol mixture in Sarda sheep with the aim to identify those able to beneficially modify ewe's metabolic status without harmful changes in red blood cell (RBC) indices. Thereafter, the selected doses were tested for their effects on ewe's ovarian activity during an induced follicular phase and compared to the effects of a hormonal treatment with equine chorionic gonadotrophin (eCG). RESULTS: Glycerol was administered alone (G groups: 90% glycerol and 10% water; % v/v) or in combination with propylene glycol (M groups: 70% glycerol, 20% propylene glycol, 10% water; % v/v). Treatments were formulated to provide 100, 75, 50 and 25% of the amount of energy supplied in previous experiments. Obtained results showed that the formulations G75 and M75 (22.5 and 18.2% on DM basis, respectively) induce metabolic changes comparable to those induced by M100. The latter dose has been already evaluated for its effects on sheep metabolism and reproductive performance. However, with these high doses, plasma osmolality increased significantly, and RBC indices showed significant alterations. The low dose groups (G25 and M25, 8.6 and 6.9% on DM basis, respectively) did not show any alterations in plasma osmolality and RBC indices, but the metabolic milieu differed markedly from that of M100. Between the medium dose groups, M50 (12.9% on DM basis) showed a more comparable milieu to M100 than G50 (15.9% on DM basis) and no RBC alterations. Therefore, M75, G75 and M50 doses were tested for their effect on ovarian functions and proved to be equally effective as eCG. CONCLUSION: The results of the present study evidenced an alteration of RBC indices, and possibly of their functions, as a side effect of glycerol administration at high doses in the diet of ewes. Therefore, protocols foreseeing the administration of glycerol should be tested for their effects on RBC indices and functions. In general terms, the medium dose of the glucogenic mixture (12.9% of dietary DM on offer) should be preferred.


Subject(s)
Glycerol/pharmacology , Ovulation/drug effects , Propylene Glycol/pharmacology , Sheep, Domestic/physiology , Administration, Oral , Animal Nutritional Physiological Phenomena , Animals , Dietary Supplements , Erythrocytes/drug effects , Female , Glycerol/administration & dosage , Gonadotropins, Equine/pharmacology , Propylene Glycol/administration & dosage
18.
Nutrients ; 12(6)2020 May 28.
Article in English | MEDLINE | ID: mdl-32481491

ABSTRACT

Accumulating evidence from animal and human studies indicates a role for vitamin D in female reproductive physiology, and numerous clinical studies have suggested its potential benefit for various aspects of human reproduction. Anti-Müllerian hormone (AMH) is an ovarian biomarker that plays an important role in folliculogenesis. It is the most sensitive ovarian reserve marker and is widely used clinically in reproductive medicine. While initial studies have suggested that vitamin D may be associated with ovarian reserve markers, including AMH, evidence has been conflicting. Currently, there is considerable debate in the field whether vitamin D has the capacity to influence ovarian reserve, as indicated by the AMH level. The current systematic review aims to evaluate and summarize the available evidence regarding the relationship between vitamin D and AMH. In total, 18 observational studies and 6 interventional studies were included in this systematic review. Cross-sectional studies have reported largely discrepant findings regarding an association between serum vitamin D and AMH levels, which are likely due to the heterogeneity in study populations, as well as the apparently complex relationship that may exist between vitamin D and AMH. However, meta-analysis of interventional studies performed herein that examined the effects of vitamin D supplementation on serum AMH levels indicates a cause-effect relationship between vitamin D and AMH, the direction of which appears to depend on a woman's ovulatory status. Serum AMH was significantly decreased following vitamin D supplementation in polycystic ovarian syndrome (PCOS) women (standardized mean difference (SMD) -0.53, 95% CI -0.91 to -0.15, p < 0.007), while it was significantly increased following vitamin D supplementation in ovulatory women without PCOS (SMD 0.49, 95% CI 0.17 to 0.80, p = 0.003). In conclusion, the results of this systematic review demonstrate that the relationship between vitamin D and AMH is a complex one, and large, randomized trials of vitamin D supplementation focusing on different vitamin D status ranges are necessary to gain more insight into the nature of this relationship and the potential benefit of vitamin D to female reproduction in general.


Subject(s)
Anti-Mullerian Hormone/blood , Dietary Supplements , Ovarian Reserve/drug effects , Reproduction/drug effects , Vitamin D/administration & dosage , Vitamin D/pharmacology , Animals , Female , Humans , Ovulation/drug effects , Polycystic Ovary Syndrome , Vitamin D/blood , Vitamin D/physiology
19.
Biol Reprod ; 103(1): 49-59, 2020 06 23.
Article in English | MEDLINE | ID: mdl-32307518

ABSTRACT

Kisspeptin has been implicated in the ovulatory process of several species of spontaneous ovulators but in only one induced ovulator. In contrast, NGF in semen is the principal trigger of ovulation in other species of induced ovulators-camelids. We tested the hypotheses that kisspeptin induces luteinizing hormone (LH) secretion in llamas through a hypothalamic mechanism, and kisspeptin neurons are the target of NGF in its ovulation-inducing pathway. In Experiment 1, llamas were given either NGF, kisspeptin, or saline intravenously, and LH secretion and ovulation were compared among groups. All llamas treated with NGF (5/5) or kisspeptin (5/5) had an elevation of LH blood concentrations after treatment and ovulated, whereas none of the saline group did (0/5). In Experiment 2, llamas were either pretreated with a gonadotropin-releasing hormone (GnRH) receptor antagonist or saline and treated 2 h later with kisspeptin. Llamas pretreated with saline had elevated plasma LH concentrations and ovulated (6/6) whereas llamas pretreated with cetrorelix did not (0/6). In Experiment 3, we evaluated the hypothalamic kisspeptin-GnRH neuronal network by immunohistochemistry. Kisspeptin neurons were detected in the arcuate nucleus, the preoptic area, and the anterior hypothalamus, establishing synaptic contacts with GnRH neurons. We found no colocalization between kisspeptin and NGF receptors by double immunofluorescence. Functional and morphological findings support the concept that kisspeptin is a mediator of the LH secretory pathway in llamas; however, the role of kisspeptins in the NGF ovulation-inducing pathway in camelids remains unclear since NGF receptors were not detected in kisspeptin neurons in the hypothalamus.


Subject(s)
Camelids, New World/physiology , Kisspeptins/pharmacology , Luteinizing Hormone/metabolism , Ovulation Induction/veterinary , Ovulation/drug effects , Ovulation/physiology , Animals , Female , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/chemistry , Kisspeptins/analysis , Kisspeptins/physiology , Male , Nerve Growth Factor/isolation & purification , Nerve Growth Factor/pharmacology , Neurons/chemistry , Receptors, Nerve Growth Factor/analysis , Semen/chemistry
20.
Curr Drug Discov Technol ; 17(5): 711-715, 2020.
Article in English | MEDLINE | ID: mdl-31429690

ABSTRACT

BACKGROUND AND OBJECTIVE: Infertility is a major problem in medical sciences. Despite recent advances in diagnosing and treatment of infertility, it is still one of the most important medical problems. The aim of this study is to review the role of the parsnip (Pastinaca sativa L), a proposed remedy as to a fertile agent in the viewpoint of Iranian traditional medicine (ITM) and review the evidence in the conventional medicine. METHODS: In this literature research, we investigated some important Persian medical and pharmaceutical manuscripts in ITM. The search was conducted with the keyword of the fertile agent, and the parsnip was one of the choices mentioned as a fertile agent which is also available. In order assess the current findings, a search was done in the PubMed and Google Scholar databases. RESULTS: In ITM, the parsnip is recognized as a stomach astringent, liver and uterine tonic and Stimulates ovulation. It is named as semen or sexual desire increaser and fertile agent. In the viewpoint of ITM, attention to the health of main or vital members of the body (including the heart, brain, and liver) in addition to the health of the urogenital system, may have led to the treatment of infertility. CONCLUSION: In some studies, the effects of the parsnip on spermatogenesis, number, and sperm motility are investigated but no studies have been done on women's infertility. This review shows that the parsnip can be as a fertile agent in female infertility. So, further clinical research is recommended.


Subject(s)
Infertility, Female/drug therapy , Infertility, Male/drug therapy , Medicine, Traditional/methods , Pastinaca , Plant Extracts/therapeutic use , Female , Humans , Iran , Male , Ovulation/drug effects , Plant Extracts/pharmacology , Sperm Motility/drug effects , Spermatogenesis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL